论文部分内容阅读
目的观察个性化血糖管理在肿瘤合并糖尿病患者中的应用效果。方法肿瘤合并糖尿病患者76例分为两组:对照组39例,采用常规护理;试验组37例,在常规护理基础上行个性化血糖管理者。比较两组血糖控制效果。结果干预后,两组患者空腹血糖、餐后2-h血糖和餐后最高血糖水平均较干预前降低(P<0.05),试验组血糖指标降低程度大于对照组(P<0.05)。试验组血糖控制总有效率高于对照组(94.59%vs.76.92%)(P<0.05),生活质量总评分、情绪功能和社会功能评分均高于对照组(P<0.05)。结论与常规护理相比,肿瘤合并糖尿病患者放疗期间采用个性化血糖管理干预可以更有效控制患者血糖水平,提高患者生活质量。
Objective To observe the effect of personalized glycemic control in patients with cancer complicated with diabetes. Methods Tumor patients with diabetes mellitus (76 cases) were divided into two groups: control group (39 cases) and routine care group (37 cases). Patients with diabetes mellitus underwent routine nursing. Compare the two groups blood glucose control effect. Results After fasting, fasting blood glucose, postprandial 2-h blood glucose and postprandial maximal blood glucose level were lower than those before intervention (P <0.05). The blood sugar level of the two groups was significantly lower than that of the control group (P <0.05). The total effective rate of glycemic control in the experimental group was higher than that in the control group (94.59% vs.76.92%, P <0.05). The total quality of life score, emotional function and social function score were higher in the experimental group than those in the control group (P <0.05). Conclusion Compared with routine care, using personalized glycemic control intervention during the radiotherapy of patients with tumor complicated with diabetes mellitus can effectively control the blood glucose level and improve the quality of life of patients.